Clinical Trials in Georgia

Showing 4581-4600 of 19,050 trials

RISE FOR HEALTH Study

NCT05365971

The RISE FOR HEALTH study (RISE) is an initiative of the Prevention of Lower Urinary Tract Symptoms (PLUS) Research Consortium, which was formed by the NIDDK in 2015 to develop the science to improve bladder health in women and girls. RISE is designed to identify risk and protective factors for bladder health and lower urinary tract symptoms (LUTS) and to estimate the distributions of bladder health and bladder health knowledge, attitudes, and beliefs in women of all ages across the life course. This will be accomplished by conducting a population-based prospective cohort study. A sample of individuals who live within the study base, i.e., the county containing each PLUS clinical research center and each adjacent county, will be invited to complete two baseline surveys and then two follow-up surveys one year later. A subset of participants will be invited to attend an in-person evaluation to collect additional clinical information and biologic specimens.

Lower Urinary Tract Symptoms

University of Minnesota3,400 participantsStarted May 2022

Birmingham, Alabama, United States • San Diego, California, United States • New Haven, Connecticut, United States +6 more locations

Active Not RecruitingPhase 365 miles

A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate

NCT02629159

The purpose of this study was to assess efficacy, including inhibition of radiographic progression, and safety with upadacitinib versus placebo and versus an active comparator, adalimumab, in adults with with moderately to severely active rheumatoid arthritis (RA) who are on a stable background of methotrexate (MTX and who have an inadequate response to MTX.

Rheumatoid Arthritis

AbbVie1,629 participantsStarted Dec 2015

Birmingham, Alabama, United States • Mesa, Arizona, United States • Peoria, Arizona, United States +367 more locations

RISE FOR HEALTH Study

A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate

Find Trials by Condition in Georgia

A Study of DKN-01 and Lenalidomide/Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Connect® MM- The Multiple Myeloma Disease Registry

A Study in Adults and Adolescents With Angelman Syndrome (STARS)

A Comparison of PT027 vs PT007 Used as Needed in Participants With Asthma

OPT-302 With Aflibercept in Neovascular Age-related Macular Degeneration (nAMD)

A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Phase 2 Study of DKN-01 in Colorectal Cancer

Vemurafenib in Children With Recurrent/Refractory BRAF Gene V600E (BRAFV600E)-Mutant Gliomas

Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer With an FGFR Alteration

Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial

A Prospective Cohort Post Market Registry Evaluating Outcomes of Bridge-Enhanced ACL Restoration (BEAR®)

A Study to Evaluate the Pharmacokinetics and Safety of INCB054707 in Participants With Normal Hepatic Function and Participants With Hepatic Impairment

Study of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lung Cancer

Safety and Immunogenicity of V540B in Healthy Adults (V540B-002).

A Study of INCB099280 in Combination With Adagrasib in Adults With Advanced Solid Tumors Harboring a KRASG12C Mutation

Radiofrequency Ablation of Atrial Fibrillation Under Apnea

SLC13A5 Deficiency Natural History Study - United States Only